Ivan Babić

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 435 citations · Full text

Chemoprevention Strategy, Cell Death, Gbm Cell Lines +16

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc

Kenta Masui, Kazuhiro Tanaka, David Akhavan et al. · Cell Metabolism · 2013 · 390 citations · Full text

Neuro-oncology, Medicine, Mtor Complex 2 +9

Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 278 citations · Full text

EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer

Ivan Babić, Erik S. Anderson, Kazuhiro Tanaka et al. · Cell Metabolism · 2013 · 158 citations · Full text

Neuro-oncology, Glycolytic Tumors, Medicine +10

De-Repression of <i>PDGFRβ</i> Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients

David Akhavan, Alexandra L. Pourzia, Alex Nourian et al. · Cancer Discovery · 2013 · 139 citations · Full text